Variation in CDKAL1 gene is associated with therapeutic response to sulphonylureas. [electronic resource]
Producer: 20130701Description: 177-83 p. digitalISSN:- 1802-9973
- Aged
- Blood Glucose -- analysis
- Cyclin-Dependent Kinase 5 -- genetics
- Diabetes Mellitus, Type 2 -- drug therapy
- Female
- Genetic Variation
- Genotype
- Humans
- Hypoglycemic Agents -- administration & dosage
- Male
- Metformin -- administration & dosage
- Middle Aged
- Sulfonylurea Compounds -- administration & dosage
- tRNA Methyltransferases
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.